Richtech Robotics Faces Securities Lawsuit Over Disputed Microsoft Partnership Claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Richtech Robotics faces securities lawsuit over false Microsoft partnership claims. Stock fell 20.87% after critical report questioned the deal's legitimacy.

Richtech Robotics Faces Securities Lawsuit Over Disputed Microsoft Partnership Claims

A federal securities class action has been initiated against Richtech Robotics Inc., alleging the company made materially false and misleading statements regarding a purported collaborative relationship with Microsoft. The litigation was prompted by a critical report released on January 29, 2026, which questioned the legitimacy of the Microsoft partnership, triggering a sharp 20.87% decline in the company's stock price that same day.

The lawsuit seeks to hold the company accountable for statements made to investors and the market regarding the nature and existence of the Microsoft deal. According to the case filing, investors who purchased Richtech Robotics securities during the relevant period may be eligible to participate in the class action as either class members or lead plaintiff candidates.

Investors seeking to assume a lead plaintiff position in the litigation must submit their applications by April 3, 2026. The law firm Faruqi & Faruqi, LLP is representing shareholders in the action and has emphasized the importance of the approaching deadline for those wishing to play an active role in the case proceedings.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 14

Related Coverage

GlobeNewswire Inc.

Inovio Investors Face April 7 Deadline in Securities Class Action Over Alleged Misstatements

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

INO
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF